GOMEZ MONTERREY, ISABEL MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.938
EU - Europa 3.300
NA - Nord America 3.200
SA - Sud America 632
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 11.179
Nazione #
US - Stati Uniti d'America 3.048
SG - Singapore 2.240
RU - Federazione Russa 1.523
CN - Cina 808
IT - Italia 543
BR - Brasile 539
HK - Hong Kong 373
VN - Vietnam 272
UA - Ucraina 240
DE - Germania 204
FI - Finlandia 162
NL - Olanda 136
IE - Irlanda 132
SE - Svezia 104
CA - Canada 92
GB - Regno Unito 87
IN - India 57
AR - Argentina 37
MX - Messico 37
FR - Francia 36
ZA - Sudafrica 33
AT - Austria 32
CI - Costa d'Avorio 31
TR - Turchia 25
ES - Italia 23
ID - Indonesia 22
PL - Polonia 22
BD - Bangladesh 20
JP - Giappone 20
KR - Corea 19
CO - Colombia 15
EC - Ecuador 14
AE - Emirati Arabi Uniti 8
BE - Belgio 8
MA - Marocco 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CL - Cile 7
IL - Israele 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
KE - Kenya 6
VE - Venezuela 6
IR - Iran 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
PT - Portogallo 5
DZ - Algeria 4
GE - Georgia 4
GR - Grecia 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
EG - Egitto 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
UG - Uganda 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GM - Gambi 1
HR - Croazia 1
MK - Macedonia 1
NA - Namibia 1
NE - Niger 1
Totale 11.164
Città #
Singapore 951
Chandler 439
Moscow 404
Hong Kong 372
Beijing 292
Jacksonville 233
Ashburn 192
Princeton 134
Santa Clara 133
Millbury 112
Amsterdam 108
Nanjing 107
Napoli 107
Los Angeles 101
Naples 89
Ho Chi Minh City 83
Hefei 81
Buffalo 73
Boston 60
Dallas 60
São Paulo 59
Des Moines 57
Ottawa 53
Wilmington 48
Redondo Beach 43
Munich 41
New York 40
The Dalles 37
Hanoi 36
Seattle 30
Dong Ket 28
San Jose 24
Turku 23
Chicago 21
Fisciano 21
London 21
Nanchang 21
Salerno 21
Shenyang 21
Mexico City 20
Montreal 20
Warsaw 20
Hebei 19
Kronberg 19
Rio de Janeiro 19
Stockholm 19
Orem 18
Biên Hòa 17
Brooklyn 17
Jiaxing 17
Seoul 17
Tianjin 17
Changsha 15
Haiphong 15
Johannesburg 15
Woodbridge 15
Denver 14
Falkenstein 14
Lawrence 14
Atlanta 13
Frankfurt am Main 13
Brasília 12
Chennai 12
Poplar 12
Da Nang 11
Milan 11
Norwalk 11
Vienna 11
Curitiba 10
Helsinki 10
Houston 10
Parma 10
Boardman 9
Hải Dương 9
Nuremberg 9
Tokyo 9
Toronto 9
Ankara 8
Charlotte 8
Dublin 8
Goiânia 8
Kochi 8
Manaus 8
Nakano 8
Phoenix 8
San Francisco 8
Bắc Giang 7
Campinas 7
North Bergen 7
Recife 7
Rome 7
Tashkent 7
Ann Arbor 6
Bắc Ninh 6
Hangzhou 6
Orange 6
Paris 6
Querétaro 6
Baronissi 5
Belo Horizonte 5
Totale 5.468
Nome #
Short-length derivatives of cell-penetrating peptides for ocular drug delivery 200
New Antiviral INSTIs: Design, Synthesis And Biological Evaluation. 142
Characterization of New TRPM8 Modulators in Pain Perception 137
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 135
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity 134
Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy 134
1,3-Dioxoperhydropyrido[2,1-c]pyrimidine derivatives as Cholecyctokinin antagonista 132
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization 130
Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators 126
Pursuing the Development of New Antiviral INSTIs 118
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 117
D-Amino Acids Containing Temporin L Analogues 114
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 113
N-substitued tryptamines as TRPM8 channel modulators 113
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 110
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 110
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 109
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 109
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities 108
Pursuing the Development of New Antiviral Entry Inhibitors 108
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 108
Urantide Conformation and Interaction with the Urotensin-II Receptor 107
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 104
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 104
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 103
Continuous-flow synthesis of thiazolidine libraries: one-pot two steps protocol optimization 103
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 102
Synthesis of a New Series of [Indoline3, 2’-thiazolidine] - Based p53 modulators 102
DTNQ-based anticancer derivatives as selective glucose penetration inhibitors 101
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 100
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 99
Development of Cyclic Peptide Inhibitors of GRK2 99
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 99
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 97
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 96
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 95
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 95
Antioxidant profile and in vitro antiproliferative and cardioprotective properties of typical red and white wines from vineyards cultivated in Scafati (Salerno, Italy) 95
Dihydrithieno[2,3-b]naphto-4,9-dione analogues as anticancer agents: Synthesis and in cell pharmacological studies. 95
A novel route to synthesize Freidinger lactams by microwave irradiation 94
Morphicetin analogues containing a new β-turn thiazolidine mimetic 92
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 92
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis 91
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 89
Sar Study Of P5u And Urantide Analogues Modified At Position 9 89
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 88
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 88
N-substituted tryptamines as TRPM8 channel modulators 86
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 86
Synthesis of 2-Alkyl(aryl)amino-(3,4,6-tri-O-acetyl-1,2-dideoxy-a-D-glucopirano)[2,1-d]-2-oxazolines and ethyl 2-[3-alkyl(aryl)ureido]-2-deoxy-b-D-glucopiranosides from acetylated 2-[3-alkyl(aryl)ureido]-2-deoxy-D-glucopyranoses 85
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 85
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structure-activity relationship studies on the substituents at N2-position 83
An efficient synthesis of 8-Amino-3-oxoindolizidine-2-carboxylic acid and derivarives as model peptidomimetics 83
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 83
A facile synthesis of 8-Amino-3-oxoindolizidine derivatives as conformationally restricted ornithyl pseudodipeptides. 81
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models 81
Tioureas derivadas de carbohidratos V. Isotiocianato y tioureas dela 2-Amino-2-desoxi-D-glicero-α-L-glucoheptopiranosa 80
D-Amino Acids Containing Temporin L Analogues 78
Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach 78
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase 77
P5U and urantide modifi ed at position 7 with Tpi 76
An efficient approach for monosulfide bridge formation in solid-phase peptide synthesis 75
Le concept d’inhibiteaurs mixtes des metallopeptidase a Zinc: application au developement de noveaux analgesiques et antihypertensives 74
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 74
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from fragment Virtual Screening 74
An Efficient Approach to Aromatic Aminomethylation Using Dichloromethane as Methylene Source 73
Phenacylthiourea and N-thiazolyl derivatives of D-glucasamine 72
Synthesis of cyclic ketomethylene dipeptides 72
Ketomethylenebestatine. Synthesis and aminopeptidase inhibition 71
Sintesis de hidrobromuros de Glucopirano-[2,1-d]-2-tiazolidinas 70
5-(Tryptophyl)amino-1,3-dioxoperhidropyrido[1,2-c]pyrimidine-based potent and selective CCK1 receptor antagonists: Structural modifications at the Tryptophan domain 70
Synthesis of quinolindione derivatives assisted by microwave irradiation 70
Cell penetrating peptides in ocular drug delivery: State of the art 70
Antioxidant and oxidative effects of grape juices 69
Conformational stability of a(25-35) in the presence of thiazolidine and imidazo[1,5-c]thiazole-5,7-dione derivatives 67
A new series of 1,3-dihydro-imidazo[1,5-c]thiazole-5,7-dione derivatives: synthesis and interaction with Aβ (25-35) amyloid peptide 66
Morphiceptin Analogues Containing a Dipeptide Mimetic Structure: An Investigation on the Bioactive Topology at μ-Receptor 66
Novel peptidomimetic as MMP2 inhibitors 66
Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors 66
Pharmacological evaluation of IQM-95,333, a highly selective CCK-A receptor antagonist with anxyolitic-like activity in animal models. 65
Synthesis of Ketomethylene-bestatine 65
Synthesis and biological activities of ketomethylene-substituted analogs of neurotensin(8-13) 64
Prolonged antinociceptive activity of pseudodipeptide analogues of Lys- Trp(Nps) and Trp(Nps)-Lys 64
Synthesis and antimicrobial evaluation of Temporin L analogues containing D-amino acids 64
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. 64
Characterization of a selective CaMKII peptide inhibitor 63
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors? 62
Antioxidant profile and in vitro cardiac radical-scavenging vs pro-oxidant effects of commercial red grape juices (Vitis vinifera L. cv. Aglianico N.). 62
Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer 62
Synthesis of Glicofurano[2,1-d]imidazolidin-2-ones 60
Stereospecific synthesis of (2R,3S)-3-Amino-2-piperidineacetic acid derivatives for use as conformational constraint in peptides 60
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 60
Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity 60
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents 59
Ketomethylene analogues of phosphoryl dipeptides related to Phosphoramidon. Synthesis and inhibition of proteases 59
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 59
Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: Potent and selective Cholecystokinin-A receptor antagonists. 57
Conformational analysis of the new temporin analogues: Gln3TA and Pro3TL 57
Design, Synthesis and Conformational Studies of New Analogues of Temporins A and L. 57
Efficient Synthesis in Solid-Phase of Freidinger-like lactams by Microwave irradiation 56
Totale 8.812
Categoria #
all - tutte 40.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021252 0 0 0 0 0 0 48 41 68 7 55 33
2021/2022672 11 5 2 14 6 30 11 16 133 48 125 271
2022/2023984 160 65 25 113 111 105 8 88 140 109 40 20
2023/2024547 21 80 68 24 32 32 9 66 13 15 134 53
2024/20253.459 189 188 46 25 58 159 397 201 371 357 1.194 274
2025/20263.967 717 502 692 674 1.105 253 24 0 0 0 0 0
Totale 11.459